H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents(CTSO)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-22-042785 Act: 34 Size: 241 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-22-035046 Act: 34 Size: 240 KB 网页链接
$Cytosorbents(CTSO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-22-000331 Act: 34 Size: 10 MB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-031614 Act: 34 Size: 429 KB 网页链接
$Cytosorbents(CTSO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-22-023820 Size: 6 KB 网页链接
$Cytosorbents(CTSO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-016944 Act: 34 Size: 13 KB 网页链接
$Cytosorbents(CTSO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-005282 Act: 34 Size: 13 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-22-010339 Act: 34 Size: 252 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-22-006917 Act: 34 Size: 274 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-22-005949 Act: 34 Size: 269 KB 网页链接